查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1511981

猫疫苗市场规模、份额、趋势分析报告：按疫苗类型、疾病类型、途径、免疫持续时间、成分、地区和细分市场预测，2024-2030 年

Cat Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type (Inactivated), By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

猫疫苗市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球猫疫苗市场规模预计将达到25亿美元，2024年至2030年复合年增长率预计为9.4%。

宠物拥有率的上升、猫的新疾病以及可支配收入的增加预计将增加猫疫苗的市场价值。此外，製药业的投资也预计将促进市场成长。

市场趋势的成长是由于饲主对猫疫苗需求的认识不断提高，促进预防性医疗保健，并确保猫科动物同伴的健康。宠物饲主现在优先考虑满足宠物饮食需求和个人价值观的产品，并依靠线上宠物品牌来轻鬆获取优质、营养的宠物用品。

猫疫苗市场报告亮点

  • 从疫苗类型来看，改良/减毒活病毒疫苗占据市场主导地位，2023年销售量最大，为50.1%。改良/减毒活病毒疫苗针对猫泛白血球减少症和疱疹病毒的有效性的证明增强了宠物饲主和兽医的信心。
  • 按疾病类型划分，由于 FRD 盛行率不断增加，2023 年猫科呼吸道疾病 (FRD) 细分市场所占份额最大，为 32.4%，最终推动了市场成长。
  • 预计猫白血病领域在预测期内的复合年增长率将达到 9.8%。
  • 从给药途径来看，注射剂占最大的市场占有率，2023年将达到77.4%。疫苗技术的持续研发正在推动注射剂市场的发展。
  • 以免疫期计算，到 2023 年，一年期疫苗将占据最大的市场占有率，达到 50.1%，美国猫科动物从业者协会(AAFP) 等兽医组织的专门且基于证据的实践证明它们是安全有效的。
  • 按组成部分来看，组合疫苗细分市场将在 2023 年占据最大的市场占有率，达到 64.0%，预计在预测期内将以 9.5% 的复合年增长率增长最快。
  • 2023 年，由于严格监督动物疫苗和维持高品质猫科动物医疗保健标准，北美以 38.1% 的收益占有率主导市场。
  • 主要企业包括 Virbac;CH Boehringer Sohn AG &Co.KG.、Elanco、Zoetis、Merck &Co.、Bioveta, as 和 IndianImmunology Ltd.。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章猫疫苗市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 猫咪疫苗市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章猫疫苗市场：按疫苗类型估计和趋势分析

  • 2023 年和 2030 年按疫苗类型分類的市场占有率份额
  • 细分仪表板
  • 全球猫疫苗市场前景：依疫苗类型划分
  • 2018-2030年市场规模、预测及趋势分析

第五章猫疫苗市场：依疾病类型估算与趋势分析

  • 2023 年和 2030 年按疾病类型市场占有率
  • 细分仪表板
  • 全球猫疫苗市场展望：按疾病类型
  • 2018-2030年市场规模、预测及趋势分析

第六章猫疫苗市场：按给药途径估计和趋势分析

  • 2023 年及 2030 年给药途径市场占有率
  • 细分仪表板
  • 全球猫疫苗市场前景：途径
  • 2018-2030年市场规模、预测及趋势分析

第七章 猫疫苗市场：依免疫期估算及趋势分析

  • 2023年及2030年免疫期市场占有率
  • 细分仪表板
  • 全球猫疫苗市场展望：按免疫时期划分
  • 2018-2030年市场规模、预测及趋势分析

第八章猫疫苗市场：按组成部分的估计和趋势分析

  • 2023 年及 2030 年零件市场占有率
  • 细分仪表板
  • 全球猫疫苗市场展望：按组成部分
  • 2018-2030年市场规模、预测及趋势分析

第九章猫疫苗市场：区域估计和趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • Virbac
    • CH Boehringer Sohn AG &Co. KG.
    • Elanco
    • Zoetis
    • Merck &Co.
    • Bioveta, as
    • Indian Immunologicals Ltd
Product Code: GVR-4-68040-321-1

Cat Vaccine Market Growth & Trends:

The global cat vaccine market size is expected to reach USD 2.5 billion by 2030 and is anticipated to expand at a CAGR of 9.4% from 2024 to 2030, according to a new report by Grand View Research, Inc.Rising pet ownership, emerging diseases in cats, and rising disposable income is expected to increase the market value for cat vaccines. Furthermore, pharmaceutical industry investments are also expected to boost market growth.

The rising market trend is due to the growing awareness among pet owners about the necessity of cat vaccines, promoting preventive healthcare, and ensuring the well-being of their feline companions. Pet owners now prioritize products that match their pets' dietary needs and personal values, turning to online pet brands for convenient access to premium and nutritious pet items.

Cat Vaccine Market Report Highlights:

  • Based on vaccine type, the modified/attenuated live segment dominated the market with the largest revenue share of 50.1% in 2023. The demonstrated efficacy of modified/attenuated live vaccines against feline panleukopenia and herpesvirus, has boosted confidence in both pet owners and veterinarians.
  • Based on disease type, the feline respiratory diseases (FRDs) segment held the largest share of 32.4% in 2023 owing to the increasing prevalence of FRDs, eventually driving market growth.
  • The feline leukemia segment is anticipated to witness the fastest CAGR of 9.8% over the forecast period.
  • Based on route of administration, the injectables segment held the largest market share, with 77.4% in 2023. Continuous research and development in vaccine technology are propelling the injectables segment in the market.
  • Based on duration of immunity, the 1-year segment held the largest market share of 50.1% in 2023 and the diligent and evidence-based practices of veterinary organizations such as the American Association of Feline Practitioners (AAFP) guide the development of safe and effective vaccines.
  • Based on component, the combined vaccine segment held the largest market share, with 64.0% in 2023, and is expected to grow at the fastest CAGR of 9.5% over the forecast period.
  • In 2023, North America dominated the market with a revenue share of 38.1% owing to the strict regulations overseeing animal vaccines and upholding high-quality feline healthcare standards.
  • Some of the major companies include Virbac; C.H. Boehringer Sohn AG & Co. KG.; Elanco; Zoetis; Merck & Co.; Bioveta, a.s.; Indian Immunologicals Ltd.; among others.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Vaccine type
    • 1.2.2. Disease type
    • 1.2.3. Route of administration
    • 1.2.4. Duration of immunity
    • 1.2.5. Component
    • 1.2.6. Region
    • 1.2.7. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Vaccine type outlook
    • 2.2.2. Disease type outlook
    • 2.2.3. Route of administration outlook
    • 2.2.4. Duration of immunity outlook
    • 2.2.5. Component outlook
    • 2.2.6. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cat Vaccines Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising pet ownership
      • 3.2.1.2. Emerging diseases in cats
      • 3.2.1.3. Rising disposable income
      • 3.2.1.4. Pharmaceutical industry investment
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Stringent regulatory policies and regulations
      • 3.2.2.2. High cost of Vaccines
  • 3.3. Cat Vaccines Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Cat Vaccines Market: Vaccine Type Estimates & Trend Analysis

  • 4.1. Vaccine Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Cat Vaccines Market by Vaccine Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 4.4.1. Modified/attenuated (live)
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Inactivated (killed)
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cat Vaccines Market: Disease Type Estimates & Trend Analysis

  • 5.1. Disease Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Cat Vaccines Market by Disease Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 5.4.1. Feline leukemia
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Feline panleukopenia (Feline distemper)
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Feline respiratory diseases
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Feline rabies
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Other diseases
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cat Vaccines Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Route of Administration Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Cat Vaccines Market by Route of Administration Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 6.4.1. Injectables
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 6.4.2. Intranasal
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Oral
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cat Vaccines Market: Duration of Immunity Estimates & Trend Analysis

  • 7.1. Duration of Immunity Market Share, 2023 & 2030
  • 7.2. Segment Dashboard
  • 7.3. Global Cat Vaccines Market by Duration of Immunity Outlook
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 7.4.1. 1 Year
      • 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 7.4.2. 3 Years
      • 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Others
      • 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cat Vaccines Market: Component Estimates & Trend Analysis

  • 8.1. Component Market Share, 2023 & 2030
  • 8.2. Segment Dashboard
  • 8.3. Global Cat Vaccines Market by Component Outlook
  • 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 8.4.1. Combined vaccine
      • 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 8.4.2. Mono vaccine
      • 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Cat Vaccines Market: Regional Estimates & Trend Analysis

  • 9.1. Regional Market Share Analysis, 2023 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. Global Regional Market Snapshot
  • 9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 9.5. North America
    • 9.5.1. U.S.
      • 9.5.1.1. Key country dynamics
      • 9.5.1.2. Regulatory framework/ reimbursement structure
      • 9.5.1.3. Competitive scenario
      • 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.5.2. Canada
      • 9.5.2.1. Key country dynamics
      • 9.5.2.2. Regulatory framework/ reimbursement structure
      • 9.5.2.3. Competitive scenario
      • 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6. Europe
    • 9.6.1. UK
      • 9.6.1.1. Key country dynamics
      • 9.6.1.2. Regulatory framework/ reimbursement structure
      • 9.6.1.3. Competitive scenario
      • 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.2. Germany
      • 9.6.2.1. Key country dynamics
      • 9.6.2.2. Regulatory framework/ reimbursement structure
      • 9.6.2.3. Competitive scenario
      • 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.3. France
      • 9.6.3.1. Key country dynamics
      • 9.6.3.2. Regulatory framework/ reimbursement structure
      • 9.6.3.3. Competitive scenario
      • 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.4. Italy
      • 9.6.4.1. Key country dynamics
      • 9.6.4.2. Regulatory framework/ reimbursement structure
      • 9.6.4.3. Competitive scenario
      • 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.5. Spain
      • 9.6.5.1. Key country dynamics
      • 9.6.5.2. Regulatory framework/ reimbursement structure
      • 9.6.5.3. Competitive scenario
      • 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.6. Norway
      • 9.6.6.1. Key country dynamics
      • 9.6.6.2. Regulatory framework/ reimbursement structure
      • 9.6.6.3. Competitive scenario
      • 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.7. Sweden
      • 9.6.7.1. Key country dynamics
      • 9.6.7.2. Regulatory framework/ reimbursement structure
      • 9.6.7.3. Competitive scenario
      • 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.6.8. Denmark
      • 9.6.8.1. Key country dynamics
      • 9.6.8.2. Regulatory framework/ reimbursement structure
      • 9.6.8.3. Competitive scenario
      • 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7. Asia Pacific
    • 9.7.1. Japan
      • 9.7.1.1. Key country dynamics
      • 9.7.1.2. Regulatory framework/ reimbursement structure
      • 9.7.1.3. Competitive scenario
      • 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.2. China
      • 9.7.2.1. Key country dynamics
      • 9.7.2.2. Regulatory framework/ reimbursement structure
      • 9.7.2.3. Competitive scenario
      • 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.3. India
      • 9.7.3.1. Key country dynamics
      • 9.7.3.2. Regulatory framework/ reimbursement structure
      • 9.7.3.3. Competitive scenario
      • 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.4. Australia
      • 9.7.4.1. Key country dynamics
      • 9.7.4.2. Regulatory framework/ reimbursement structure
      • 9.7.4.3. Competitive scenario
      • 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.5. South Korea
      • 9.7.5.1. Key country dynamics
      • 9.7.5.2. Regulatory framework/ reimbursement structure
      • 9.7.5.3. Competitive scenario
      • 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.7.6. Thailand
      • 9.7.6.1. Key country dynamics
      • 9.7.6.2. Regulatory framework/ reimbursement structure
      • 9.7.6.3. Competitive scenario
      • 9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8. Latin America
    • 9.8.1. Brazil
      • 9.8.1.1. Key country dynamics
      • 9.8.1.2. Regulatory framework/ reimbursement structure
      • 9.8.1.3. Competitive scenario
      • 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.2. Mexico
      • 9.8.2.1. Key country dynamics
      • 9.8.2.2. Regulatory framework/ reimbursement structure
      • 9.8.2.3. Competitive scenario
      • 9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.8.3. Argentina
      • 9.8.3.1. Key country dynamics
      • 9.8.3.2. Regulatory framework/ reimbursement structure
      • 9.8.3.3. Competitive scenario
      • 9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.9. MEA
    • 9.9.1. South Africa
      • 9.9.1.1. Key country dynamics
      • 9.9.1.2. Regulatory framework/ reimbursement structure
      • 9.9.1.3. Competitive scenario
      • 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.2. Saudi Arabia
      • 9.9.2.1. Key country dynamics
      • 9.9.2.2. Regulatory framework/ reimbursement structure
      • 9.9.2.3. Competitive scenario
      • 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.3. UAE
      • 9.9.3.1. Key country dynamics
      • 9.9.3.2. Regulatory framework/ reimbursement structure
      • 9.9.3.3. Competitive scenario
      • 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 9.9.4. Kuwait
      • 9.9.4.1. Key country dynamics
      • 9.9.4.2. Regulatory framework/ reimbursement structure
      • 9.9.4.3. Competitive scenario
      • 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 10.2. Company/Competition Categorization
  • 10.3. Vendor Landscape
    • 10.3.1. List of key distributors and channel partners
    • 10.3.2. Key customers
  • 10.4. Company Profiles
    • 10.4.1. Virbac
      • 10.4.1.1. Company overview
      • 10.4.1.2. Financial performance
      • 10.4.1.3. Product benchmarking
      • 10.4.1.4. Strategic initiatives
    • 10.4.2. C.H. Boehringer Sohn AG & Co. KG.
      • 10.4.2.1. Company overview
      • 10.4.2.2. Financial performance
      • 10.4.2.3. Product benchmarking
      • 10.4.2.4. Strategic initiatives
    • 10.4.3. Elanco
      • 10.4.3.1. Company overview
      • 10.4.3.2. Financial performance
      • 10.4.3.3. Product benchmarking
      • 10.4.3.4. Strategic initiatives
    • 10.4.4. Zoetis
      • 10.4.4.1. Company overview
      • 10.4.4.2. Financial performance
      • 10.4.4.3. Product benchmarking
      • 10.4.4.4. Strategic initiatives
    • 10.4.5. Merck & Co.
      • 10.4.5.1. Company overview
      • 10.4.5.2. Financial performance
      • 10.4.5.3. Product benchmarking
      • 10.4.5.4. Strategic initiatives
    • 10.4.6. Bioveta, a.s.
      • 10.4.6.1. Company overview
      • 10.4.6.2. Financial performance
      • 10.4.6.3. Product benchmarking
      • 10.4.6.4. Strategic initiatives
    • 10.4.7. Indian Immunologicals Ltd
      • 10.4.7.1. Company overview
      • 10.4.7.2. Financial performance
      • 10.4.7.3. Product benchmarking
      • 10.4.7.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America cat vaccines market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 4 North America cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 5 North America cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 6 North America cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 7 North America cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 8 U.S. cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 9 U.S. cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 10 U.S. cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 11 U.S. cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 12 U.S. cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 13 Canada cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 14 Canada cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 15 Canada cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 16 Canada cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 17 Canada cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 18 Europe cat vaccines market, by region, 2018 - 2030 (USD Million)
  • Table 19 Europe cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 20 Europe cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 21 Europe cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 22 Europe cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 23 Europe cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 24 Germany cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 25 Germany cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 26 Germany cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 27 Germany cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 28 Germany cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 29 UK cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 30 UK cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 31 UK cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 32 UK cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 33 UK cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 34 France cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 35 France cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 36 France cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 37 France cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 38 France cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 39 Italy cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 40 Italy cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 41 Italy cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 42 Italy cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 43 Italy cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 44 Spain cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 45 Spain cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 46 Spain cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 47 Spain cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 48 Spain cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 49 Denmark cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 50 Denmark cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 51 Denmark cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 52 Denmark cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 53 Denmark cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 54 Sweden cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 55 Sweden cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 56 Sweden cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 57 Sweden cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 58 Sweden cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 59 Norway cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 60 Norway cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 61 Norway cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 62 Norway cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 63 Norway cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific cat vaccines market, by region, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 67 Asia Pacific cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 68 Asia Pacific cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 69 Asia Pacific cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 70 China cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 71 China cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 72 China cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 73 China cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 74 China cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 75 Japan cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 76 Japan cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 77 Japan cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 78 Japan cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 79 Japan cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 80 India cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 81 India cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 82 India cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 83 India cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 84 India cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 85 South Korea cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 86 South Korea cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 87 South Korea cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 88 South Korea cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 89 South Korea cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 90 Australia cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 91 Australia cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 92 Australia cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 93 Australia cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 94 Australia cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 95 Thailand cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 96 Thailand cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 97 Thailand cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 98 Thailand cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 99 Thailand cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 100 Latin America cat vaccines market, by region, 2018 - 2030 (USD Million)
  • Table 101 Latin America cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 102 Latin America cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 103 Latin America cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 104 Latin America cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 105 Latin America cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 106 Brazil cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 107 Brazil cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 108 Brazil cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 109 Brazil cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 110 Brazil cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 111 Mexico cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 112 Mexico cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 113 Mexico cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 114 Mexico cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 115 Mexico cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 116 Argentina cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 117 Argentina cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 118 Argentina cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 119 Argentina cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 120 Argentina cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 121 MEA cat vaccines market, by region, 2018 - 2030 (USD Million)
  • Table 122 MEA cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 123 MEA cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 124 MEA cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 125 MEA cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 126 MEA cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 127 South Africa cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 128 South Africa cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 129 South Africa cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 130 South Africa cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 131 South Africa cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 132 Saudi Arabia cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 133 Saudi Arabia cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 134 Saudi Arabia cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 135 Saudi Arabia cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 136 Saudi Arabia cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 137 UAE cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 138 UAE cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 139 UAE cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 140 UAE cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 141 UAE cat vaccines market, by component, 2018 - 2030 (USD Million)
  • Table 142 Kuwait cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
  • Table 143 Kuwait cat vaccines market, by disease type, 2018 - 2030 (USD Million)
  • Table 144 Kuwait cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
  • Table 145 Kuwait cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
  • Table 146 Kuwait cat vaccines market, by component, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cat vaccines market: market outlook
  • Fig. 9 Cat vaccines competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Cat vaccines market driver impact
  • Fig. 14 Cat vaccines market restraint impact
  • Fig. 15 Cat vaccines market: Vaccine type movement analysis
  • Fig. 16 Cat vaccines market: Vaccine type outlook and key takeaways
  • Fig. 17 Modified/Attenuated Live market estimates and forecast, 2018 - 2030
  • Fig. 18 Inactivated (Killed) estimates and forecast, 2018 - 2030
  • Fig. 19 Others estimates and forecast, 2018 - 2030
  • Fig. 20 Cat vaccines market: Disease type movement analysis
  • Fig. 21 Cat vaccines market: Disease type outlook and key takeaways
  • Fig. 22 Feline leukemia market estimates and forecasts, 2018 - 2030
  • Fig. 23 Feline panleukopenia market estimates and forecasts, 2018 - 2030
  • Fig. 24 Feline respiratory diseases market estimates and forecasts, 2018 - 2030
  • Fig. 25 Feline rabies diseases market estimates and forecasts, 2018 - 2030
  • Fig. 26 Other diseases market estimates and forecasts, 2018 - 2030
  • Fig. 27 Cat vaccines market: route of administration movement analysis
  • Fig. 28 Cat vaccines market: route of administration outlook and key takeaways
  • Fig. 29 Injectables market estimates and forecasts, 2018 - 2030
  • Fig. 30 Intranasal market estimates and forecasts, 2018 - 2030
  • Fig. 31 Oral market estimates and forecasts, 2018 - 2030
  • Fig. 32 Cat vaccines market: duration of immunity movement analysis
  • Fig. 33 Cat vaccines market: duration of immunity outlook and key takeaways
  • Fig. 34 1 Year market estimates and forecasts, 2018 - 2030
  • Fig. 35 3 Year market estimates and forecasts, 2018 - 2030
  • Fig. 36 Others market estimates and forecasts, 2018 - 2030
  • Fig. 37 Cat vaccines market: component movement analysis
  • Fig. 38 Cat vaccines market: component outlook and key takeaways
  • Fig. 39 Combined vaccines market estimates and forecasts, 2018 - 2030
  • Fig. 40 Mono vaccines market estimates and forecasts, 2018 - 2030
  • Fig. 41 Global cat vaccines market: Regional movement analysis
  • Fig. 42 Global cat vaccines market: Regional outlook and key takeaways
  • Fig. 43 Global cat vaccines market share and leading players
  • Fig. 44 North America market share and leading players
  • Fig. 45 Europe market share and leading players
  • Fig. 46 Asia Pacific market share and leading players
  • Fig. 47 Latin America market share and leading players
  • Fig. 48 Middle East & Africa market share and leading players
  • Fig. 49 North America: SWOT
  • Fig. 50 Europe SWOT
  • Fig. 51 Asia Pacific SWOT
  • Fig. 52 Latin America SWOT
  • Fig. 53 MEA SWOT
  • Fig. 54 North America, by country
  • Fig. 55 North America
  • Fig. 56 North America market estimates and forecasts, 2018 - 2030
  • Fig. 57 U.S.
  • Fig. 58 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 59 Canada
  • Fig. 60 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 61 Europe
  • Fig. 62 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 63 UK
  • Fig. 64 UK market estimates and forecasts, 2018 - 2030
  • Fig. 65 Germany
  • Fig. 66 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 67 France
  • Fig. 68 France market estimates and forecasts, 2018 - 2030
  • Fig. 69 Italy
  • Fig. 70 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 71 Spain
  • Fig. 72 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 73 Denmark
  • Fig. 74 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 75 Sweden
  • Fig. 76 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 77 Norway
  • Fig. 78 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 79 Asia Pacific
  • Fig. 80 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 81 China
  • Fig. 82 China market estimates and forecasts, 2018 - 2030
  • Fig. 83 Japan
  • Fig. 84 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 85 India
  • Fig. 86 India market estimates and forecasts, 2018 - 2030
  • Fig. 87 Thailand
  • Fig. 88 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 89 South Korea
  • Fig. 90 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 91 Australia
  • Fig. 92 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 93 Latin America
  • Fig. 94 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 95 Brazil
  • Fig. 96 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 97 Mexico
  • Fig. 98 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 99 Argentina
  • Fig. 100 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 101 Middle East and Africa
  • Fig. 102 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 103 South Africa
  • Fig. 104 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 105 Saudi Arabia
  • Fig. 106 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 107 UAE
  • Fig. 108 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 109 Kuwait
  • Fig. 110 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 111 Market share of key market players - Cat vaccines market